Ilyang Pharmaceutical Co.,Ltd (KOSE:A007570) announces a share repurchase program. Under the plan, the company will repurchase KRW 3,000 million worth of its shares pursuant to a contract with Samsung Securities Co., Ltd. The purpose behind the program is to stabilize the stock price and enhancement of shareholder value. The company will make repurchases until September 14, 2022.

As of March 9, 2022, the company had 838,850 shares in treasury within scope available for dividend and 41,634 shares in treasury under other capacities.